PMID- 25925372\r\nOWN - NLM\r\nSTAT- Publisher\r\nDA  - 20150430\r\nLR  - 20150505\r\nIS  - 1941-7705 (Electronic)\r\nIS  - 1941-7713 (Linking)\r\nDP  - 2015 Apr 29\r\nTI  - Incidence and Predictors of Cognitive Decline in Patients with Left Ventricular\r\n      Assist Devices.\r\nLID - CIRCOUTCOMES.115.001856 [pii]\r\nAB  - BACKGROUND: After left ventricular assist device (LVAD) placement for advanced\r\n      heart failure, increased cerebral perfusion should result in improved cognitive\r\n      function. However, stroke (a well-known LVAD complication) and subclinical\r\n      cerebral ischemia may result in transient or permanent cognitive decline. We\r\n      sought to describe the incidence and predictors of cognitive decline after LVAD\r\n      using a valid, sensitive assessment tool. METHODS AND RESULTS: Among 4419\r\n      patients in the Interagency Registry for Mechanically Assisted Circulatory\r\n      Support who underwent LVAD implantation between May 2012 and December 2013,\r\n      cognitive function was assessed in 1173 patients with the Trail Making B Test\r\n      before LVAD and at 3, 6, and 12 months. The test detects several forms of\r\n      cognitive impairment, including subclinical stroke. Cognitive decline was defined\r\n      as a clinically important increase during follow-up using a moderate Cohen d\r\n      effect size of 0.5xbaseline SD (32 s). The cumulative incidence of cognitive\r\n      decline in the year after LVAD implantation, treating death and transplantation\r\n      as competing risks, was 29.2\%. In adjusted analysis, older age (>/=70 versus <50 \r\n      years; hazard ratio, 2.24; 95\% confidence interval 1.46-3.44; Ptrend<0.001) and\r\n      destination therapy (hazard ratio, 1.42; 95\% confidence interval, 1.05-1.92) were\r\n      significantly associated with greater risk of cognitive decline. CONCLUSIONS:\r\n      Cognitive decline occurs commonly in patients in the year after LVAD and is\r\n      associated with older age and destination therapy. These results could have\r\n      important implications for patient selection and improved communication of risks \r\n      before LVAD implantation. Additional studies are needed to explore the\r\n      association between cognitive decline and subsequent stroke, health status, and\r\n      mortality in patients after LVAD.\r\nCI  - (c) 2015 American Heart Association, Inc.\r\nFAU - Fendler, Timothy J\r\nAU  - Fendler TJ\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.). fendlert@umkc.edu.\r\nFAU - Spertus, John A\r\nAU  - Spertus JA\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Gosch, Kensey L\r\nAU  - Gosch KL\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Jones, Philip G\r\nAU  - Jones PG\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Bruce, Jared M\r\nAU  - Bruce JM\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Nassif, Michael E\r\nAU  - Nassif ME\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Flint, Kelsey M\r\nAU  - Flint KM\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Dunlay, Shannon M\r\nAU  - Dunlay SM\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Allen, Larry A\r\nAU  - Allen LA\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nFAU - Arnold, Suzanne V\r\nAU  - Arnold SV\r\nAD  - From the Mid-America Heart Institute, Kansas City, MO (T.J.F., J.A.S., K.L.G.,\r\n      P.G.J., S.V.A.); University of Missouri-Kansas City (T.J.F., J.A.S., J.M.B.,\r\n      S.V.A.); Washington University School of Medicine, Saint Louis, MO (M.E.N.);\r\n      University of Colorado School of Medicine, Aurora (K.M.F., L.A.A.); and Mayo\r\n      Clinic of Rochester, MN (S.M.D.).\r\nLA  - ENG\r\nGR  - HHSN268201100025C/HL/NHLBI NIH HHS/United States\r\nGR  - K23 HL116799/HL/NHLBI NIH HHS/United States\r\nGR  - T32 HL110837/HL/NHLBI NIH HHS/United States\r\nPT  - JOURNAL ARTICLE\r\nDEP - 20150429\r\nTA  - Circ Cardiovasc Qual Outcomes\r\nJT  - Circulation. Cardiovascular quality and outcomes\r\nJID - 101489148\r\nPMC - PMC4418227\r\nMID - NIHMS678189\r\nOTO - NOTNLM\r\nOT  - brain ischemia\r\nOT  - heart-assist devices\r\nOT  - mild cognitive impairment\r\nEDAT- 2015/05/01 06:00\r\nMHDA- 2015/05/01 06:00\r\nCRDT- 2015/05/01 06:00\r\nPMCR- 2016/10/29 00:00\r\nAID - CIRCOUTCOMES.115.001856 [pii]\r\nAID - 10.1161/CIRCOUTCOMES.115.001856 [doi]\r\nPST - aheadofprint\r\nSO  - Circ Cardiovasc Qual Outcomes. 2015 Apr 29. pii: CIRCOUTCOMES.115.001856.\r\nassist support devices\r\nheart failure\r\nheart transplant\r\n